dabigatran has been researched along with Alcohol Abuse in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bardou, M; Billionnet, C; Drouin, J; Maura, G; Neumann, A; Weill, A | 1 |
| Armstrong, J; Pascu, O; Ridgley, J; Vlad, I | 1 |
| Adelmeijer, J; Bos, S; Boyett, SL; Daita, K; Lisman, T; Potze, W; Sanyal, AJ; Siddiqui, MS | 1 |
3 other study(ies) available for dabigatran and Alcohol Abuse
| Article | Year |
|---|---|
Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a propensity-weighted nationwide cohort study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alcoholism; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; France; Humans; Liver Failure, Acute; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Risk; Rivaroxaban; Young Adult | 2020 |
Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.
Topics: Alcoholism; Anticoagulants; Blood Coagulation Tests; Critical Care; Dabigatran; Drug Overdose; Female; Half-Life; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Middle Aged; Monitoring, Physiologic; Pulmonary Embolism; Risk Factors; Young Adult | 2016 |
Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease.
Topics: Adult; Alcoholism; Anticoagulants; Dabigatran; Enoxaparin; Female; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pyrazoles; Pyridones; Thrombosis | 2017 |